
Faslodex
Brand for: Fulvestrant
My Prescription
Payment
Select pharmacy




$70.40
$15.00 due at pharmacy
$70.40 - $15.00 = $55.40
$55.40 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$70.40
Print or send this coupon to your phone
About Faslodex
Drug Details
Fulvestrant, also known by its brand name Faslodex, is a hormone therapy used in the treatment of certain types of breast cancer, specifically hormone receptor (HR)-positive, advanced, or metastatic breast cancer. This medication is administered via an injection into the muscles. After the initial doses, it is typically given on a monthly basis. Fulvestrant can be used alone or alongside other anticancer treatments. The drug operates by blocking the effects of estrogen, a hormone needed by many breast cancer cells to grow and spread, thereby slowing down the progression of the tumor. Compared to chemotherapy, Fulvestrant generally has fewer serious side effects, making it a preferable option for some patients. Always consult with your healthcare provider to ensure that Fulvestrant is appropriate for your condition and to discuss any potential interactions with other medications you may be taking.
Faslodex (Fulvestrant) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 5ML of 250MG/5ML | 1 Syringe | $70.40 | $70.40 |
| 5ML of 250MG/5ML | 2 Syringes | $122.80 | $61.40 |
| 5ML of 250MG/5ML | 3 Syringes | $175.20 | $58.40 |
Faslodex FAQs
Faslodex is not a form of chemotherapy. It is a type of hormone therapy used to treat certain types of breast cancer by blocking the effects of estrogen in the body.
Faslodex is used for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. It is often prescribed when the cancer has progressed following anti-estrogen therapy.
The decision to stop taking fulvestrant should be made in consultation with a healthcare provider. It is typically based on factors such as the effectiveness of the treatment, side effects experienced, and the progression of the condition being treated. It is important for the patient to follow the guidance of their oncologist or healthcare team regarding the duration of treatment with fulvestrant.
Faslodex is neither chemotherapy nor immunotherapy. It is a type of hormone therapy used to treat certain types of breast cancer.
The survival rate for patients taking Faslodex (fulvestrant) can vary depending on several factors, including the stage of breast cancer, previous treatments, and individual patient characteristics. Faslodex is commonly used in hormone receptor-positive metastatic breast cancer, often in postmenopausal women. Clinical trials have shown that Faslodex can improve progression-free survival, but overall survival rates can differ based on the specific clinical context and combination with other therapies. It is important for patients to discuss their individual prognosis and treatment outcomes with their healthcare provider.